Applied DNA Launches Mpox Clade I And Clade II Testing Service
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences, Inc. has expanded its clinical testing services to include detection of Mpox Clade I and Clade II, following interactions with regulatory bodies.
September 11, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Applied DNA Sciences has launched a new testing service for Mpox Clade I and II, potentially increasing its market reach and revenue.
The launch of the new testing service for Mpox Clade I and II by Applied DNA Sciences could lead to increased demand for its services, potentially boosting revenue. The involvement of regulatory bodies like NYSDOH and FDA adds credibility and may facilitate market acceptance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100